(Q34160004)

31 July 2017

0 references

1 reference

title

Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy (English)

1 reference

31 July 2017

0 references

0 references

S Shukla

1

1 reference

31 July 2017

A Shukla

series ordinal

2

1 reference

31 July 2017

S Mehboob

series ordinal

3

1 reference

31 July 2017

S Guha

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

20 January 2011

1 reference

Alimentary Pharmacology & Therapeutics

31 July 2017

published in

1 reference

31 July 2017

volume

33

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

662-671

1 reference

Minimal hepatic encephalopathy impairs fitness to drive.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Minimal hepatic encephalopathy matters in daily life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

The effect of fatigue on driving skills in patients with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Quality of life in cirrhotics with minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

A randomized controlled trial of acarbose in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Gut flora and hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04574.X

10.1111/J.1365-2036.2010.04574.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference